Despite great advances with the introduction of ticagrelor and prasugrel in the treatment of acute coronary syndromes (ACS), the risk of thrombosis and bleeding remains significant and affects the choice of clinicians in the treatment of the single patient. Large registries are effective tools to explore patterns of drug administration and adherence to guideline recommendations in real-world clinical practice.
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry / Marcucci, Rossella; Patti, Giuseppe; Calabrò, Paolo; Gori, Anna Maria; Grossi, Guido; Cirillo, Plinio; Pengo, Vittorio; Gresele, Paolo; Pignatelli, Pasquale; Antonucci, Emilia; di Mario, Carlo; Valente, Serafina; Palareti, Gualtiero. - In: PLOS ONE. - ISSN 1932-6203. - ELETTRONICO. - 14:(2019), pp. e0219676-e0219690. [10.1371/journal.pone.0219676]
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry
Marcucci, Rossella;Gori, Anna Maria
;GROSSI, GUIDO;di Mario, Carlo;
2019
Abstract
Despite great advances with the introduction of ticagrelor and prasugrel in the treatment of acute coronary syndromes (ACS), the risk of thrombosis and bleeding remains significant and affects the choice of clinicians in the treatment of the single patient. Large registries are effective tools to explore patterns of drug administration and adherence to guideline recommendations in real-world clinical practice.
| File | Dimensione | Formato | |
|---|---|---|---|
|
PLOSONE "019.pdf
accesso aperto
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Open Access
Dimensione
675.42 kB
Formato
Adobe PDF
|
675.42 kB | Adobe PDF |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
